1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
yifan900
Articles (128) 

5 Companies Hit 52-Week Highs

Recently, multiple companies have all managed to achieve yearly highs

September 18, 2018 | About:

According to GuruFocus' list of 52-week highs, these guru stocks have reached their 52-week highs.

Nike Inc. (NYSE:NKE) reached the 52-week high of $83.49

Nike Inc. designs, develops and markets footwear, apparel, equipment and accessory products. It sells its products through Nike-owned in-line and factory retail stores and internet websites. Nike is the world's largest designer and wholesaler of athletic footwear and apparel. The firm sells to more than 50,000 retail accounts through a network of more than 1,142 company-owned stores (about 30% of revenue including online sales), and independent distributors and licensees in 170 countries. Nike brand sales in North America account for 43% of revenue, followed by Western Europe (18%), emerging markets (12%) and China (13%), with the remainder from Japan and Central and Eastern Europe. The Converse brand accounts for 6% of sales.

The price of Nike Inc. shares has reached $83.49, which is 0.5% off the 52-week high of $83.90. Nike Inc. has a market cap of $133.63 billion; its shares were traded around $83.49 with a P/E ratio of 72.60 and P/S ratio of 3.78. The trailing 12-month dividend yield of Nike Inc. stocks is 0.96%. The forward dividend yield of Nike Inc. stocks is 0.96%. Nike Inc. had an annual average earnings growth of 10.30% over the past 10 years. GuruFocus rated Nike Inc. the business predictability rank of 5-star.

NIKE Inc. (NYSE:NKE) recently reported financial results for its fiscal 2018 fourth quarter and full year ended May 31, 2018. Fourth quarter revenue increased 13% to $9.8 billion driven by strong double-digit revenue growth in international markets and NIKE Direct globally, and a return to growth in North America. Diluted earnings per share for the fourth quarter rose 15% to 69 cents. Net income increased 13% to $1.1 billion primarily due to strong global revenue growth.

Executive Vice President, Human Resource Monique S. Matheson sold 17,000 shares of Nike stock on Sept. 11 at the price of $83.15 per share. The price of the stock has increased by 0.41% since.

Synopsys Inc. (NASDAQ:SNPS) reached the 52-week high of $102.72

Synopsys Inc. is a software development company. It supplies electronic design automation software used by engineers to design and test integrated circuits. It provides software and hardware used to develop the electronic systems that incorporate chips. Synopsys is a provider of electronic design automation software and intellectual property products to designers, engineers and developers. The software enables designers to automate the integrated circuit design process and reduce errors, and verify that the design behaves as intended. Its intellectual property products include solutions for wired and wireless interfaces, logic libraries and embedded memories, and configurable processor cores. The firm derives revenue from the sale of software licenses, as well as from maintenance and professional fees. 

The price of Synopsys Inc. shares has reached $102.72, which is 0.7% off the 52-week high of $103.40. Synopsys Inc. has a market cap of $15.26 billion; its shares were traded around $102.72 with a P/E ratio of 277.62 and P/S ratio of 5.18. Synopsys Inc. had an annual average earnings growth of 8.30% over the past 10 years. GuruFocus rated Synopsys Inc. the business predictability rank of 5-star.

Synopsys Inc. recently reported results for its third quarter of fiscal year 2018. Revenue was $779.7 million, compared to $695.4 million for the third quarter of fiscal year 2017, an increase of 12.1%. On a generally accepted accounting principles (GAAP) basis, net income was $79.4 million, or 52 cents per share, compared to $116.8 million, or 75 cents per share, for the third quarter of fiscal 2017. On a non-GAAP basis, net income was $145.6 million, or 95 cents per share, compared to non-GAAP net income of $141.6 million, or 92 cents per share, for the third quarter of fiscal 2017.

Co-CEO and President Chi-foon Chan sold 3,609 shares of Synopsys stock on Aug. 24 at the price of $101.85 per share. The price of the stock has increased by 0.85% since. General Counsel John F. Runkel Jr. sold 10,000 shares of Synopsys stock on Aug. 30 at the price of $102 per share. The price of the stock has increased by 0.71% since. Executive Vice President, Sales and Corporate Marketing Joseph W. Logan sold 20,000 shares of Synopsys stock on Aug. 24 at the price of $101.43 per share. The price of the stock has increased by 1.27% since.

Veeva Systems Inc. (NYSE:VEEV) reached the 52-week high of $106.92

Veeva Systems Inc. is a provider of industry-specific, cloud-based software solutions for the life sciences industry. Veeva Systems largely provides cloud-based software to customers in the life sciences industry for customer relationship, content and data management. Veeva CRM is a suite of applications that help pharmaceutical and biotechnology companies market and sell products to healthcare providers. Veeva Vault, a product built on proprietary software, is a cloud-based application built to manage content and associated data.

The price of Veeva Systems Inc. shares has reached $106.92, which is 0.6% off the 52-week high of $107.57. Veeva Systems Inc. has a market cap of $15.45 billion; its shares were traded around $106.92 with a P/E ratio of 102.81 and P/S ratio of 21.60. Veeva Systems Inc. had an annual average earnings growth of 26.50% over the past five years.

Veeva Systems Inc. recently announced results for its fiscal second quarter ended July 31, 2018. Total revenues for the second quarter were $209.6 million, up from $167.8 million one year ago, an increase of 25% year-over-year. Second quarter operating income was $52.8 million, compared to $38.1 million one year ago, an increase of 39% year-over-year. Second quarter net income was $50.3 million, compared to $38.6 million one year ago, an increase of 30% year-over-year.

Chief Financial Officer Timothy S. Cabral sold 50,000 shares of Veeva Systems stock on Sept. 5 at the price of $101.49 per share. The price of the stock has increased by 5.35% since. He also sold 25,000 shares of Veeva Systems stock on Sept. 12 at the price of $103.08 per share. The price of the stock has increased by 3.73% since. Chief Marketing Officer Eleni Nitsa Zuppas sold 7,200 shares of Veeva Systems stock on Sept. 11 at the price of $103.30 pe share. The price of the stock has increased by 3.5% since.

Motorola Solutions Inc. (NYSE:MSI) reached the 52-week high of $126.76

Motorola Solutions Inc. is a communications equipment manufacturer. It provides communications infrastructure, devices such as two-way portable radios, and an array of communications network management and support services. Motorola Solutions is a global communications equipment manufacturer, creating devices such as two-way portable radios, boasting an array of communications network management, and offering support services. The company operates through two segments: products and services. The products segment is composed of radios, batteries, base stations, consoles, and repeaters primarily utilized by first responders through government contracts, although the company has a smaller commercial segment. The services business is composed of integration services, such as infrastructure implementation, and software offerings, such as 911 command center products.

The price of Motorola Solutions Inc. shares has reached $126.76, which is 1.9% off the 52-week high of $129.20. Motorola Solutions Inc. has a market cap of $20.57 billion; its shares were traded around $126.76 with and P/S ratio of 3.12. The trailing 12-month dividend yield of Motorola Solutions Inc. stocks is 1.64%. The forward dividend yield of Motorola Solutions Inc. stocks is 1.64%.

Motorola Solutions Inc. recently reported its earnings results for the second quarter of 2018. Sales increased $263 million to $1.8 billion, or 18% from the year-ago quarter, driven by growth in all regions. GAAP operating margin was 15.5% of sales, compared with 17.4% in the year-ago quarter. Operating cash flow was $425 million, compared with $173 million of operating cash generated in the year-ago quarter.

Chairman and CEO Gregory Q. Brown sold 65,873 shares of Motorola Solutions stock on Sept. 12 at the price of $125.94 per share. The price of the stock has increased by 0.65% since. Executive Vice President and Chief Financial Officer Gino A. Bonanotte sold 23,201 shares of Motorola Solutions stock on Sept. 12 at the price of $125.97 per share. The price of the stock has increased by 0.63% since. Executive Vice President, General Counsel and Chief Admin Officer Mark S. Hacker sold 102,628 shares of Motorola Solutions stock on Sept. 7 at the price of $127.01 per share. The price of the stock has decreased by 0.2% since.

Boston Scientific Corp. (NYSE:BSX) reached the 52-week high of $37.39

Boston Scientific Corp. is a developer, manufacturer, and marketer of medical devices. The firm markets its devices to health-care professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales. Boston Scientific produces less-invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract tests and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

The price of Boston Scientific Corp. shares has reached $37.39, which is 0.9% off the 52-week high of $37.72. Boston Scientific Corp. has a market cap of $51.71 billion; its shares were traded around $37.39 with a P/E ratio of 103.86 and P/S ratio of 5.50.

Boston Scientific Corp. recently announced earnings for the second quarter ended June 30, 2018. It generated sales of $2.49 billion during the quarter. This represents growth of 10.3% on a reported basis, 8.6% on an operational basis and 7.9% on an organic basis, all compared to the prior-year period. The company reported GAAP earnings of $555 million or 40 cents per share, compared to GAAP earnings of $146 million or 11 cents per share a year ago, and achieved adjusted earnings per share of 41 cents for the period, compared to 32 cents a year ago.

Chairman, President and CEO Michael F. Mahoney sold 116,666 shares of Boston Scientific stock on Sept. 11 at the price of $35.88 per share. The price of the stock has increased by 4.21% since.

Note: I do not own these stocks.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by yifan900


User Generated Screeners


Marcelo SommerBrazil - High Piotroski
johnbarberHF_Stalwarts
pbarker46Dividend basic
aboer52-41 Downies
aboer52-29 DN Prof▼5Pred▼1Pi▼5J
aboer52-36 Bottom 20% of industries
aboer52-165 Bad ROE
aboer52-225 dn Op Mgn < 20th percenti
aboer52-451 dn Warn><1 Finan<6 Profit
aboer52-88 Profit<=5 Warnings >=3
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK